|
How many volunteers were present at the Congress? : |
about 1000 |
|
Delegates from which countries presented in the congress? : |
USA, France, Germany, England, Spain, Italy, India, Australia, Canada, Japan, Korea |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
FDA, NIH, WHO, USP |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
There are a considerable amount of interest toward application of natural product for therapeutic purpose specially in the case of cancer. Most of the questions were in the field of phytochemistry and the potential application of other plants for cancer therapy. |
|
If you met staff members, please list their full names & positions. : |
1- Prof. Bruce Mann, Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient.
2- Prof. Alastair Thompson, Active in translational laboratory research, he built a breast cancer research program over 15 years in Dundee, including a xenograft program and tissue banking facility with a focus on the p53 network and drug development. He has successfully supervised 20 PhD or research MD students and currently has 4 students completing PhDs. The impact of over 200 peer reviewed research papers has included global firsts demonstrating the effect of drugs in vivo in animal models and in human cancers.
He continues to provide leadership in trials and clinical translational research with colleagues in Europe and Australasia while establishing clinical trials and laboratory collaborations in the US, through membership of the American Society of Clinical Oncology, American Association of Cancer Research, South West Oncology Group and Translational Breast Cancer Research Consortium. |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
No more action is required. No more action is required.No more action is required. No more action is required.No more action is required. No more action is required. No more action is required. No more action is required.No more action is required. No more action is required No more action is required.No more action is required. No more action is required No more action is required.No more action is required. No more action is required |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
1)high cost of life in Barcelona including accommodation, taxi, foods
2)The registration fee was expensive according to Euro conversion rate with Rial |
|
Please give a briefing of your own observations and outcomes of the congress: : |
There were educational panel, refreshment courses and workshop. At the same time 6 hall were active, and the arrangement was so great, all of the presentation were on time. the commercial sections was full of new technologies, and procedures ready to replace with old and traditional protocols. The new anticancer agents with lower side effects were another interesting point of the exhibition section. The congress was well-organized and every things were held on time. After doing registration and paying registration fee participants could take part in every panels without any extra charge but workshops.
The other point was enthusiastic between participants to take part in the panels. Almost 10 minutes before each panel all the sits were occupied and there were no more free sits so, many persons while sitting on the floor were following the presentations. |